Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 267

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Risk of cancer in women receiving hormone replacement therapy

Adami, Hans‐Olov, Persson, Ingemar, Hoover, Robert, Schairer, Catharine, Bergkvist, Leif·1989·International Journal of Cancer

Abstract

Cancer risk following treatment with non‐contraceptive estrogens was studied in a population‐based cohort of 23,244 women. Complete follow‐up for an average of 6.7 years revealed 1,087 incident cancers versus 962.5 expected (relative risk/RR/= 1.13; 95% confidence interval 1.10–1.20). We confirmed the recent findings of a more detailed analysis of the same cohort, based on a I‐year shorter follow‐up period, namely: a markedly increased risk of endometrial cancer (RR = 1.8; 1.5–2.1), notably in women receiving potent estrogens, i.e., conjugated estrogens or estradiol (RR = 2.0; 1.6–2.4), and a slightly increased risk of breast cancer (RR = 1.1; 1.0–1.2). A slightly decreased risk of invasive cervical cancer (RR = 0.8; 0.5–1.2) is most likely due to more frequent smear taking than in the background population. There was no increase in the risk of cancer of ovary (RR = 1.0; 0.8‐1.2), pancreas (RR = 0.8; 0.5–1.2), large bowel (RR = 1.0; 0.8–1.2) or kidney (RR = 1.0; 0.7–1.4). The risk of developing cancer in liver or biliary tract was lower than expected (RR = 0.4; 0.2–0.7), particularly in women who had used potent estrogens (RR = 0.3; 0.1–0.6), an unexpected finding which warrants further studies. Increased risks of malignant melanoma (RR = 1.5; 1.0–2.1) and lung cancer (RR = 1.3; 0.9–1.7) need cautious interpretation because of their low magnitude, the absence of a biological gradient when subgroups were analyzed and the slightly higher prevalence of smokers in the cohort than in the background population.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ijc.2910440515

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Cited by

See all 267

Metadata

Authors
Adami, H., Persson, I., Hoover, R., Schairer, C., & Bergkvist, L.
Venue
International Journal of Cancer
Publisher
Wiley
Published
1989-11-15
Volume
44
Issue
5
Pages
833-839
ISSN
  • 0020-7136 (ISSN-L)
  • 1097-0215
OpenAlex
W2011701047
Cited by
267
References
29
FWCI
3.55
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Risk of cancer in women receiving hormone replacement therapy. https://app.cochat.ai/papers/10.1002/ijc.2910440515
The paper
Adami, H., Persson, I., Hoover, R., Schairer, C., & Bergkvist, L. (1989). Risk of cancer in women receiving hormone replacement therapy. International Journal of Cancer. https://doi.org/10.1002/ijc.2910440515

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.